Current Cardiology Reports

, Volume 6, Issue 2, pp 89–95 | Cite as

Aortic valve disease: Current recommendations

  • Naomi F. Botkin
  • Gerard P. Aurigemma


Aortic stenosis is a common valvular abnormality. Surgical valve replacement is the standard of care for symptomatic patients with severe aortic stenosis and is appropriate for certain asymptomatic patients. Statin therapy may slow progression of the disease. Contrary to conventional wisdom, vasodilator therapy may in fact be safe and effective in certain instances of severe aortic stenosis. Chronic aortic regurgitation is commonly treated with vasodilator therapy, which is certainly indicated for the asymptomatic patient with hypertension. Surgery is recommended for left ventricular dilatation, diminished ventricular systolic function, or symptoms.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lindroos M, Kupari M, Heikkila J, et al.: Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993, 21:1220–1225.PubMedCrossRefGoogle Scholar
  2. 2.
    Ross J, Braunwald E: Aortic stenosis. Circulation 1968, 37(Suppl):V61-V67.Google Scholar
  3. 3.
    Otto CM, Kuusisto J, Reichenbach DD, et al.: Characterization of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994, 90:844–853.PubMedGoogle Scholar
  4. 4.
    Olsson M, Thyberg J, Nilsson J: Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999, 19:1218–1222.PubMedGoogle Scholar
  5. 5.
    Faggiano P, Rusconi C, Sabatini T, et al.: Congestive heart failure in patients with valvular aortic stenosis. Cardiology 1995, 86:120–129.PubMedCrossRefGoogle Scholar
  6. 6.
    Ross J: Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol 1985, 5:811–826.PubMedCrossRefGoogle Scholar
  7. 7.
    Wagner S, Selzer A: Patterns of progression of aortic stenosis: a longitudinal hemodynamic study. Circulation 1982, 65:709–712.PubMedGoogle Scholar
  8. 8.
    Brener SJ, Duffy CI, Thomas JD, et al.: Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol 1995, 25:305–310.PubMedCrossRefGoogle Scholar
  9. 9.
    Faggiano P, Ghizzoni G, Sorgato A, et al.: Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992, 70:229–233.PubMedCrossRefGoogle Scholar
  10. 10.
    Bellamy MF, Pellikka PA, Klarich KW, et al.: Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002, 40:1723–1730. This is the first prospective study to demonstrate that statin therapy is associated with slower progression of AS.PubMedCrossRefGoogle Scholar
  11. 11.
    Turina J, Hess O, Sepulcri F, et al.: Spontaneous course of aortic valve disease. Eur Heart J 1987, 8:471–483.PubMedGoogle Scholar
  12. 12.
    Davies SW, Gershlick AH, Balcon R: Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 1991, 12:10–14.PubMedGoogle Scholar
  13. 13.
    Horstkotte D, Loogen F: The natural history of aortic stenosis. Eur Heart J 1988, 9:E57-E64.Google Scholar
  14. 14.
    Neiderberger J, Schima H, Maurer G, et al.: Importance of pressure recovery for the assessment of aortic stenosis by Doppler ultrasound. Circulation 1996, 94:1934–1940.Google Scholar
  15. 15.
    Bonow RO, Carabello B, de Leon AC Jr, et al.: Guidelines for the management of patients with valvular heart disease: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 1998, 98:1949–1984.PubMedGoogle Scholar
  16. 16.
    Kennedy KD, Nishimura RA, Holmes DR, et al.: Natural history of moderate aortic stenosis. J Am Coll Cardiol 1991, 17:313–319.PubMedCrossRefGoogle Scholar
  17. 17.
    Cannon JD, Zile MR, Crawford FA, et al.: Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients. J Am Coll Cardiol 1992, 20:1517–1523.PubMedCrossRefGoogle Scholar
  18. 18.
    Oh JK, Taliercio CP, Holmes DR, et al.: Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol 1988, 11:1227–1234.PubMedCrossRefGoogle Scholar
  19. 19.
    Faggiano P, Aurigemma GP, Rusconi C, et al.: Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am Heart J 1996, 132:408–417.PubMedCrossRefGoogle Scholar
  20. 20.
    Pellikka PA, Nishimura RA, Bailey KR, et al.: The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990, 15:1012–1017.PubMedCrossRefGoogle Scholar
  21. 21.
    Otto CM, Burwash IG, Legget ME, et al.: Prospective study of asymptomatic valvular aortic stenosis. Circulation 1997, 95:2262–2270.PubMedGoogle Scholar
  22. 22.
    Rosenhek R, Binder T, Porenta G, et al.: Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000, 343:611–617.PubMedCrossRefGoogle Scholar
  23. 23.
    Amato MC, Moffa PJ, Werner KE, et al.: Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001, 86:381–386.PubMedCrossRefGoogle Scholar
  24. 24.
    Connolly HM, Oh JK, Orszulak TA, et al.: Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Circulation 1997, 85:2395–2400.Google Scholar
  25. 25.
    Smith N, McAnulty JH, Rahimtoola SH: Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978, 58:255–264.PubMedGoogle Scholar
  26. 26.
    Clyne CA, Arrighi JA, Maron BJ: Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis. Am J Cardiol 1991, 68:1469–1476.PubMedCrossRefGoogle Scholar
  27. 27.
    Fighali SF, Avendafio A, Elayda MA, et al.: Early and late mortality of patients undergoing aortic valve replacement after previous coronary artery bypass graft surgery. Circulation 1995, 95(Suppl II):II–163-II–168.Google Scholar
  28. 28.
    Sundt TM, III, Murphy SF, Barzilai B, et al.: Previous coronary artery bypass grafting is not a risk factor for aortic valve replacement. Ann Thorac Surg 1997, 64:651–658.PubMedCrossRefGoogle Scholar
  29. 29.
    Diethrich EB: The treatment of aortic stenosis: is valvuloplasty ever an alternative to surgery? J Interv Cardiol 1993, 6:7–13.PubMedGoogle Scholar
  30. 30.
    Kastrup J, Wennevold A, Thuesen L, et al.: Short- and long-term survival after aortic balloon valvuloplasty for calcified aortic stenosis in 137 elderly patients. Dan Med Bull 1994, 41:362–365.PubMedGoogle Scholar
  31. 31.
    Cribier AG: Implantable valves for aortic stenosis. Presented at the Transcatheter Cardiovascular Therapeutics conference. Washington, DC: September 15–19, 2003. http://www.tctmd.comGoogle Scholar
  32. 32.
    Pitt B, Mancini GB, Ellis SG, et al.: Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events: PLAC I investigation. J Am Coll Cardiol 1995, 26:1133–1139.PubMedCrossRefGoogle Scholar
  33. 33.
    Jukema JW, Bruschke AV, van Boven AJ, et al.: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995, 91:2528–2540.PubMedGoogle Scholar
  34. 34.
    Novaro G, Tiong IY, Pearce BL, et al.: Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001, 104:2205–2209.PubMedGoogle Scholar
  35. 35.
    Khot UN, Novaro GM, Popovic ZB, et al.: Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003, 348:1756–1763. Nitroprusside was administered to 25 patients with severe AS and depressed LV function who required intensive care. The drug was demonstrated to be safe and effective at improving cardiac output.PubMedCrossRefGoogle Scholar
  36. 36.
    Monin J, Monchi M, Gest V, et al.: Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients. J Am Coll Cardiol 2001, 37:2101–2107.PubMedCrossRefGoogle Scholar
  37. 37.
    Brogan WC, Grayburn PA, Lange RA, et al.: Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient. J Am Coll Cardiol 1993, 21:1657–1660.PubMedCrossRefGoogle Scholar
  38. 38.
    Connolly HM, Oh JK, Schaff HV, et al.: Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction. Circulation 2000, 101:1940–1946.PubMedGoogle Scholar
  39. 39.
    Blitz LR, Gorman M and Herrmann HC. Results of aortic valve replacement for aortic stenosis with relatively low transvalvular pressure gradients. Am J Cardiol 1998, 81:358–362.PubMedCrossRefGoogle Scholar
  40. 40.
    Schwammenthal E, Vered Z, Moshkowitz Y, et al.: Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction. Chest 2001, 119:1766–1777.PubMedCrossRefGoogle Scholar
  41. 41.
    Nishimura RA, Grantham JA, Connolly HM, et al.: Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function. Circulation 2002, 106:809–813. This study demonstrated the utility of dobutamine administration in the catheterization laboratory for preoperative risk stratification for low-gradient AS.PubMedCrossRefGoogle Scholar
  42. 42.
    Ishii K, Hirota Y, Suwa M, et al.: Natural history and left ventricular response in chronic aortic regurgitation. Am J Cardiol 1996, 78:357–361.PubMedCrossRefGoogle Scholar
  43. 43.
    Borer JS, Hochreiter C, Herrold EM, et al.: Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998, 97:525–534.PubMedGoogle Scholar
  44. 44.
    Dujardin KS, Enriquez-Sarano M, Schaff HV, et al.: Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation 1999, 99:1851–1857.PubMedGoogle Scholar
  45. 45.
    Landzberg JS, Pflugfelder PW, Cassidy MM, et al.: Etiology of the Austin Flint murmur. J Am Coll Cardiol 1992, 20:408–413.PubMedCrossRefGoogle Scholar
  46. 46.
    Perry GJ, Helmcke F, Nanda NC, et al.: Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987, 9:952–959.PubMedCrossRefGoogle Scholar
  47. 47.
    Tam JW, Antecol D, Kim HH, et al.: Low dose dobutamine echocardiography in the assessment of contractile reserve to predict the outcome of valve replacement for chronic aortic regurgitation. Can J Cardiol 1999, 15:73–79.PubMedGoogle Scholar
  48. 48.
    Grayburn PA: Vasodilator therapy for chronic aortic and mitral regurgitation. Am J Med Sci 2000, 320:202–208.PubMedCrossRefGoogle Scholar
  49. 49.
    Scognamiglio R, Fasoli G, Ponchia A, et al.: Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990, 16:424–429.PubMedCrossRefGoogle Scholar
  50. 50.
    Scognamiglio R, Rahimtoola SH, Fasoli G, et al.: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994, 331:689–694.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Naomi F. Botkin
    • 1
  • Gerard P. Aurigemma
    • 1
  1. 1.Division of Cardiovascular MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations